Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q3 2024
Institutional positions in Cidara Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +2 vs. Q2 2024
- Shares held
- 3.31M
- +1.94M (+141.9%) vs. Q2 2024
- Total value
- $35.6M
- +$19.3M (+118.3%) vs. Q2 2024
- New holders
- 7
- 8 more added
- Sold out
- 5
- 0 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 703,080 | $7.56M | 0.09% | +703,080 | New |
| Bain Capital Life Sciences Investors, LLC | 703,080 | $7.56M | 0.79% | +703,080 | New |
| BVF Inc | 703,065 | $7.56M | 0.22% | +360,010+104.9% | Added |
| Monashee Investment Management LLC | 369,099 | $3.97M | 0.43% | 00.0% | Unchanged |
| Checkpoint Capital L.P. | 182,426 | $1.96M | 0.97% | +37,009+25.5% | Added |
| Vanguard Group Inc | 180,535 | $1.94M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 97,817 | $1.05M | 0.00% | +2,300+2.4% | Added |
| Alethea Capital Management, LLC | 79,908 | $859.0K | 0.62% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 56,725 | $609.8K | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 52,898 | $568.8K | 0.00% | +9,771+22.7% | Added |
| BlackRock, Inc. | 48,920 | $525.9K | 0.00% | +48,920 | New |
| Adage Capital Partners GP, L.L.C. | 42,755 | $459.6K | 0.00% | +42,755 | New |
| Northern Trust Corp | 31,787 | $341.7K | 0.00% | +31,787 | New |
| Schonfeld Strategic Advisors LLC | 19,500 | $209.6K | 0.00% | +100+0.5% | Added |
| Millennium Management LLC | 13,919 | $149.6K | 0.00% | +13,919 | New |
| State Street Corp | 13,576 | $145.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,877 | $63.2K | 0.00% | +4,410+300.6% | Added |
| Tower Research Capital LLC (TRC) | 1,115 | $12.0K | 0.00% | +369+49.5% | Added |
| Russell Investments Group, Ltd. | 855 | $9.19K | 0.00% | 00.0% | Unchanged |
| Manchester Capital Management LLC | 470 | $5.05K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 400 | $4.30K | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 250 | $2.00K | 0.00% | +250 | New |
| Morgan Stanley | 169 | $1.82K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 106 | $1.14K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 40 | $430 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 39 | $419 | 0.00% | +5+14.7% | Added |
| BNP Paribas Arbitrage, SA | 17 | $183 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 0 | $0 | 0.00% | −13,103−100.0% | Sold out |
| Wetzel Investment Advisors, Inc. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |